Business · 04/12/2000Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of SangStat Medical Corp.'s Cyclosporine ANDA
Summary
The FDA has withdrawn its approval of SangStat Medical Corp.'s abbreviated new drug application for Cyclosporine Oral Solution, following a class II recall in 2000, and the company has waived its right to a hearing.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →